Hello, Guest!
  • Friday, November 22, 2024

CSRA’s DynPort Vaccine Company Gets Orphan Drug Designation on Plague Vaccine


TYSONS CORNER, VA, March 10, 2017 ” A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and Drug Administration on a plague vaccine it is developing as a potential pre-exposure prophlaxis treatment against Yersinia pestis infection, ExecutiveBiz reported Thursday.

The company said Wednesday the designation enables DynPort Vaccine Company to receive incentives in its work to develop the recombinant rF1V vaccine as part of the Defense Department‘s medical countermeasure efforts against bioterrorism.

About Executive Mosaic: Founded in 2002, Executive Mosaic is a leadership organization and media company. Executive Mosaic offers highly coveted executive events, breaking business news on the Government Contracting industry, and delivers robust and reliable content through seven influential websites and four consequential E-newswires. Headquarters are located in Tysons Corner, VA. www.executivemosaic.com

Contact:
David Smith
(703) 226-7002
[email protected]

Video of the Day

Related Articles

Navy Awards 8 Companies Spots on $701M Ship Maintenance IDIQ Contract Awards

Navy Awards 8 Companies Spots on $701M Ship Maintenance IDIQ

Eight companies have won spots on a five-year, $701 million indefinite-delivery/indefinite-quantity contract from the U.S. Navy to repair, maintain and modernize non-nuclear surface ships homeported in Mayport, Florida. The contractors will conduct continuous maintenance emergent maintenance of the ship and provide short-term support to the Chief of Naval Operations, the Department of Defense said Wednesday.

Air Force Posts Solicitation for Potential $5.7B Combat Air Force Support Follow-On Contract News

Air Force Posts Solicitation for Potential $5.7B Combat Air Force Support Follow-On Contract

The U.S. Air Force has begun seeking proposals for a potential $5.7 billion follow-on multiple-award contract to provide combat air forces contracted air support services to help protect U.S. assets against advanced airborne threats. CAF CAS II seeks to procure non-personal services for realistic advanced adversary air threats and close air support threats to support

Northrop Lands $167M Navy Contract Modification for G/ATOR Radar Tech Contract Awards

Northrop Lands $167M Navy Contract Modification for G/ATOR Radar Tech

Northrop Grumman (NYSE: NOC) has secured a potential $167.1 million contract modification from the U.S. Navy to supply four lot 6 full-rate production Ground/Air Task Oriented Radar systems. Marine Corps Systems Command is the contracting activity and will obligate the full contract amount using the U.S. Air Force’s other procurement funds for fiscal year 2024,